Lataa...
Immuno-PET imaging of the hepatocyte growth factor receptor Met using the one-armed antibody Onartuzumab (MetMAb)
The over-expression and -activation of hepatocyte growth factor receptor (Met) in various cancers has been linked to increased proliferation, progression to metastatic disease, and drug resistance. Developing a PET imaging agent to assess Met expression would aid in diagnosis and monitoring response...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3982858/ https://ncbi.nlm.nih.gov/pubmed/22917884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.102293 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|